Charbel Sandroussi
Charbel Sandroussi
Clinical Associate Professor, University of Sydney
Adresă de e-mail confirmată pe sydney.edu.au
Citat de
Citat de
Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion
D DuBay, C Sandroussi, L Sandhu, S Cleary, M Guba, MS Cattral, ...
Annals of surgery 253 (1), 166-172, 2011
A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer
JM Laurence, PD Tran, K Morarji, GD Eslick, VWT Lam, C Sandroussi
Journal of Gastrointestinal Surgery 15, 2059-2069, 2011
Systematic review and meta‐analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma
S Abbas, C Sandroussi
HPB 15 (7), 492-503, 2013
Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series
G Sapisochin, N Goldaracena, S Astete, JM Laurence, D Davidson, ...
Annals of surgical oncology 22, 2286-2294, 2015
Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?
G Spolverato, A Vitale, A Cucchetti, I Popescu, HP Marques, L Aldrighetti, ...
Cancer 121 (22), 3998-4006, 2015
Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma
C Sandroussi, LA Dawson, M Lee, M Guindi, S Fischer, A Ghanekar, ...
Transplant international 23 (3), 299-306, 2010
Conditional probability of long-term survival after liver resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 535 patients
G Spolverato, Y Kim, A Ejaz, S Alexandrescu, H Marques, L Aldrighetti, ...
JAMA surgery 150 (6), 538-545, 2015
Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor
DJ Arnaoutakis, Y Kim, C Pulitano, V Zaydfudim, MH Squires, D Kooby, ...
Annals of surgery 261 (2), 361, 2015
Is hepatic resection for large or multifocal intrahepatic cholangiocarcinoma justified? Results from a multi-institutional collaboration
G Spolverato, Y Kim, S Alexandrescu, I Popescu, HP Marques, ...
Annals of surgical oncology 22, 2218-2225, 2015
Coping with newly diagnosed upper gastrointestinal cancer: a longitudinal qualitative study of family caregivers’ role perception and supportive care needs
J Shaw, J Harrison, J Young, P Butow, C Sandroussi, D Martin, ...
Supportive care in cancer 21, 749-756, 2013
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence
L Sandhu, C Sandroussi, M Guba, M Selzner, A Ghanekar, MS Cattral, ...
Liver Transplantation 18 (3), 315-322, 2012
Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation
DA DuBay, C Sandroussi, JR Kachura, CS Ho, JR Beecroft, CM Vollmer, ...
Hpb 13 (1), 24-32, 2011
Targeting DNA damage response and replication stress in pancreatic cancer
SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ...
Gastroenterology 160 (1), 362-377. e13, 2021
A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms
N Abraham, L Lemech, C Sandroussi, D Sullivan, J May
Journal of vascular surgery 41 (3), 377-380, 2005
HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer
H Brunton, G Caligiuri, R Cunningham, R Upstill-Goddard, UM Bailey, ...
Cell reports 31 (6), 107625, 2020
Preoperative assessment of postoperative liver function: the importance of residual liver volume
C Pulitano, M Crawford, D Joseph, L Aldrighetti, C Sandroussi
Journal of Surgical Oncology 110 (4), 445-450, 2014
Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries
SW Ryu, R Saw, RA Scolyer, M Crawford, JF Thompson, C Sandroussi
Journal of surgical oncology 108 (2), 129-135, 2013
A multi‐institution analysis of outcomes of liver‐directed surgery for metastatic renal cell cancer
I Hatzaras, AL Gleisner, C Pulitano, C Sandroussi, K Hirose, O Hyder, ...
HPB 14 (8), 532-538, 2012
Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs
J Kokkinos, RMC Ignacio, G Sharbeen, C Boyer, E Gonzales-Aloy, ...
Biomaterials 240, 119742, 2020
Improving psychosocial outcomes for caregivers of people with poor prognosis gastrointestinal cancers: a randomized controlled trial (Family Connect)
JM Shaw, JM Young, PN Butow, T Badgery-Parker, I Durcinoska, ...
Supportive Care in Cancer 24, 585-595, 2016
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20